JP2005289928A - コラーゲン合成促進アミノ酸組成物 - Google Patents
コラーゲン合成促進アミノ酸組成物 Download PDFInfo
- Publication number
- JP2005289928A JP2005289928A JP2004109506A JP2004109506A JP2005289928A JP 2005289928 A JP2005289928 A JP 2005289928A JP 2004109506 A JP2004109506 A JP 2004109506A JP 2004109506 A JP2004109506 A JP 2004109506A JP 2005289928 A JP2005289928 A JP 2005289928A
- Authority
- JP
- Japan
- Prior art keywords
- parts
- mass
- amino acid
- acid composition
- arginine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
【解決手段】L−アルギニンを10〜40質量部および/またはL−グルタミンを10〜40質量部、ならびに、L−バリンを5〜20質量部、L−イソロイシンを8〜30質量部およびL−ロイシンを10〜35質量部含有することを特徴とするコラーゲン合成促進アミノ酸組成物。
【選択図】 図1
Description
Claims (5)
- L−アルギニンを10〜40質量部および/またはL−グルタミンを10〜40質量部、ならびに、L−バリンを5〜20質量部、L−イソロイシンを8〜30質量部およびL−ロイシンを10〜35質量部含有することを特徴とするコラーゲン合成促進アミノ酸組成物。
- L−アルギニンを10〜40質量部および/またはL−グルタミンを10〜40質量部、ならびに、L−バリンを5〜20質量部、L−イソロイシンを8〜30質量部およびL−ロイシンを10〜35質量部含有することを特徴とする皮膚老化防止アミノ酸組成物。
- L−アルギニンを10〜40質量部および/またはL−グルタミンを10〜40質量部、ならびに、L−バリンを5〜20質量部、L−イソロイシンを8〜30質量部およびL−ロイシンを10〜35質量部含有することを特徴とする骨粗しょう症抑制アミノ酸組成物。
- L−アルギニンを10〜40質量部および/またはL−グルタミンを10〜40質量部、ならびに、L−バリンを5〜20質量部、L−イソロイシンを8〜30質量部およびL−ロイシンを10〜35質量部含有することを特徴とする腱、靱帯再生促進アミノ酸組成物。
- L−アルギニンを10〜40質量部および/またはL−グルタミンを10〜40質量部、ならびに、L−バリンを5〜20質量部、L−イソロイシンを8〜30質量部およびL−ロイシンを10〜35質量部含有することを特徴とする創傷又は熱傷治癒アミノ酸組成物。
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004109506A JP4815752B2 (ja) | 2004-04-01 | 2004-04-01 | アミノ酸含有飲食品 |
| US11/092,890 US20050250850A1 (en) | 2004-04-01 | 2005-03-30 | Amino acid composition promoting collagen synthesis |
| EP05252047A EP1582208B1 (en) | 2004-04-01 | 2005-03-31 | An amino acid compositions for promoting collagen synthesis |
| US11/477,436 US7645796B2 (en) | 2004-04-01 | 2006-06-30 | Amino acid composition promoting collagen synthesis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004109506A JP4815752B2 (ja) | 2004-04-01 | 2004-04-01 | アミノ酸含有飲食品 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011063169A Division JP2011137037A (ja) | 2011-03-04 | 2011-03-04 | コラーゲン合成促進アミノ酸組成物 |
| JP2011164806A Division JP5370429B2 (ja) | 2011-07-08 | 2011-07-08 | コラーゲン合成促進アミノ酸組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005289928A true JP2005289928A (ja) | 2005-10-20 |
| JP4815752B2 JP4815752B2 (ja) | 2011-11-16 |
Family
ID=34880128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004109506A Expired - Lifetime JP4815752B2 (ja) | 2004-04-01 | 2004-04-01 | アミノ酸含有飲食品 |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US20050250850A1 (ja) |
| EP (1) | EP1582208B1 (ja) |
| JP (1) | JP4815752B2 (ja) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007161688A (ja) * | 2005-12-16 | 2007-06-28 | Hiroshima Univ | 軟骨生成促進剤 |
| WO2007111238A1 (ja) | 2006-03-23 | 2007-10-04 | Kyowa Hakko Kogyo Co., Ltd. | 組織コラーゲン合成促進用経口剤 |
| WO2008072663A1 (ja) * | 2006-12-12 | 2008-06-19 | Ajinomoto Co., Inc. | ステロイド療法における副作用の改善・抑制用組成物 |
| JP2008247896A (ja) * | 2007-03-07 | 2008-10-16 | Shizuokaken Koritsu Daigaku Hojin | 透析患者用経口アミノ酸組成物 |
| KR101485113B1 (ko) * | 2013-04-09 | 2015-01-21 | 롯데푸드 주식회사 | 피부 광노화 예방 및 개선을 위한 프롤린 베이스 혼합 아미노산 조성물 |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMO20060339A1 (it) * | 2006-10-23 | 2008-04-24 | Clelia Barini | Metodo cosmetico di tonificazione del derma |
| EP2033689A1 (en) * | 2007-08-22 | 2009-03-11 | Italfarmacia S.r.l. | Injectable dermatological composition for treatment of the wrinkles |
| FR2924613B1 (fr) * | 2007-12-10 | 2012-12-21 | Oreal | Utilisation cosmetique de proteines de type hsp27. |
| EP2153814A1 (en) | 2008-08-05 | 2010-02-17 | Isdin S.A. | Use of compositions comprising urea |
| EP2153815A1 (en) | 2008-08-05 | 2010-02-17 | Isdin S.A. | Use of urea containing compositions |
| EP2235038B1 (de) * | 2008-12-30 | 2019-06-05 | GKL-Biotec AG | Tetrapeptidkombination |
| US20130281913A1 (en) | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
| US11116841B2 (en) | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
| AU2013315304A1 (en) | 2012-09-14 | 2015-03-26 | Klox Technologies Inc. | Cosmetic biophotonic compositions |
| US11266685B2 (en) | 2014-06-09 | 2022-03-08 | Klox Technologies Inc. | Silicone-based biophotonic compositions and uses thereof |
| US11135146B2 (en) | 2015-12-28 | 2021-10-05 | Klox Technologies Limited | Peroxide-less biophotonic compositions and methods |
| EP3402524A4 (en) | 2016-01-11 | 2019-08-07 | Klox Technologies Limited | BIOPHOTONIC COMPOSITIONS FOR THE TREATMENT OF SKIN AND SOFT PARTICLES WITH NON-RESISTANT AND RESISTANT INFECTIONS |
| EP3463268B1 (en) | 2016-05-23 | 2021-11-03 | Klox Technologies Limited | Biophotonic compositions and uses thereof |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| EP3558374A4 (en) | 2016-12-23 | 2020-08-12 | Klox Technologies Inc. | BIOPHOTONIC COMPOSITIONS CONSISTING OF LICHEN EXTRACT AND THEIR USE IN THE TREATMENT OF SKIN DISORDERS |
| JP2020517703A (ja) * | 2017-04-28 | 2020-06-18 | アクセラ・ヘルス・インコーポレイテッドAxcella Health Inc. | アミノ酸組成物及び外傷性脳損傷の治療のためのそれらの使用 |
| CU20200012A7 (es) | 2017-08-14 | 2021-02-04 | Axcella Health Inc | Composiciones de aminoácidos para el tratamiento de enfermedad hepática |
| MA52971A (fr) | 2018-06-20 | 2021-04-28 | Axcella Health Inc | Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle |
| US11938108B2 (en) * | 2018-07-25 | 2024-03-26 | Ajinomoto Co., Inc. | Composition for improving joint function |
| GB2579036A (en) * | 2018-11-15 | 2020-06-10 | Rejuvenated Ltd | Compositions comprising amino acids |
| BE1030451B1 (fr) * | 2022-10-26 | 2023-11-10 | Alphascience Res | Composition dermatologique |
| EP4371419A1 (en) * | 2022-11-15 | 2024-05-22 | Avea Life AG | Non-therapeutic use of a composition for maintaining or prolonging collagen homeostasis in a living organism during aging |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56133213A (en) * | 1980-03-21 | 1981-10-19 | Masatoshi Fumiiri | Remedy for scar |
| JPH08198748A (ja) * | 1995-01-27 | 1996-08-06 | Ajinomoto Co Inc | アミノ酸栄養組成物 |
| US5576351A (en) * | 1989-12-29 | 1996-11-19 | Mcgaw, Inc. | Use of arginine as an immunostimulator |
| JPH0952828A (ja) * | 1995-08-10 | 1997-02-25 | Sasaki Kagaku Kogyo Kk | アミノ酸組成剤およびその使用方法 |
| JPH11130669A (ja) * | 1997-10-28 | 1999-05-18 | Ajinomoto Co Inc | 褥瘡予防治療用アミノ酸栄養剤 |
| JP2002003372A (ja) * | 2000-06-20 | 2002-01-09 | Ajinomoto Co Inc | 造血および栄養状態改善用アミノ酸組成物 |
| US6346264B1 (en) * | 1999-04-27 | 2002-02-12 | International Health Products And Services Ltd. | Supplement for restoring growth hormone levels |
| WO2002087562A1 (en) * | 2001-04-26 | 2002-11-07 | Novartis Nutrition Ag | Use of protein and essential amino acids to treat amenorrhea and related disorders |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1050756A (ja) * | 1964-09-10 | 1900-01-01 | ||
| IL78342A (en) * | 1985-04-04 | 1991-06-10 | Gen Hospital Corp | Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof |
| US5719119A (en) * | 1985-12-18 | 1998-02-17 | British Technology Group, Ltd. | Parenteral nutrition therapy with amino acids |
| WO1993006834A1 (en) * | 1991-10-07 | 1993-04-15 | Otsuka Pharmaceutical Factory, Inc. | Enteral preparation for cancer therapy |
| US5326569A (en) * | 1992-12-23 | 1994-07-05 | Abbott Laboratories | Medical foods for the nutritional support of child/adult metabolic diseases |
| US5733884A (en) * | 1995-11-07 | 1998-03-31 | Nestec Ltd. | Enteral formulation designed for optimized wound healing |
| US6221836B1 (en) * | 1996-07-26 | 2001-04-24 | Paxton King Beale | Composition of pyruvate and anabolic protein and method for increasing fat loss in a mammal |
| US6048846A (en) * | 1998-02-26 | 2000-04-11 | Cochran; Timothy M. | Compositions used in human treatment |
| FR2792202B1 (fr) * | 1999-04-19 | 2003-06-13 | Pharmascience Lab | Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait |
| US6511696B2 (en) * | 2000-12-13 | 2003-01-28 | Novartis Nutrition Ag | Infant formula with free amino acids and nucleotides |
| US6864242B2 (en) * | 2001-03-05 | 2005-03-08 | Stephen P. Ernest | Enteral formulation |
| US6906036B2 (en) * | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
| US20040058309A1 (en) * | 2001-10-12 | 2004-03-25 | Junji Washizu | Plasma supplement and use in liver assist systems |
| US20030091601A1 (en) * | 2001-11-13 | 2003-05-15 | Abat Inc. | Use of topical arginine to enhance wound healing |
| JP4970694B2 (ja) * | 2002-12-02 | 2012-07-11 | 株式会社明治 | 持続性筋肉疲労改善剤 |
| US9192593B2 (en) * | 2006-08-30 | 2015-11-24 | Ajinomoto Co., Inc. | Amino-acid containing composition for inhibiting accumulation of fat |
-
2004
- 2004-04-01 JP JP2004109506A patent/JP4815752B2/ja not_active Expired - Lifetime
-
2005
- 2005-03-30 US US11/092,890 patent/US20050250850A1/en not_active Abandoned
- 2005-03-31 EP EP05252047A patent/EP1582208B1/en not_active Ceased
-
2006
- 2006-06-30 US US11/477,436 patent/US7645796B2/en active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56133213A (en) * | 1980-03-21 | 1981-10-19 | Masatoshi Fumiiri | Remedy for scar |
| US5576351A (en) * | 1989-12-29 | 1996-11-19 | Mcgaw, Inc. | Use of arginine as an immunostimulator |
| JPH08198748A (ja) * | 1995-01-27 | 1996-08-06 | Ajinomoto Co Inc | アミノ酸栄養組成物 |
| JPH0952828A (ja) * | 1995-08-10 | 1997-02-25 | Sasaki Kagaku Kogyo Kk | アミノ酸組成剤およびその使用方法 |
| JPH11130669A (ja) * | 1997-10-28 | 1999-05-18 | Ajinomoto Co Inc | 褥瘡予防治療用アミノ酸栄養剤 |
| US6346264B1 (en) * | 1999-04-27 | 2002-02-12 | International Health Products And Services Ltd. | Supplement for restoring growth hormone levels |
| JP2002003372A (ja) * | 2000-06-20 | 2002-01-09 | Ajinomoto Co Inc | 造血および栄養状態改善用アミノ酸組成物 |
| WO2002087562A1 (en) * | 2001-04-26 | 2002-11-07 | Novartis Nutrition Ag | Use of protein and essential amino acids to treat amenorrhea and related disorders |
Non-Patent Citations (2)
| Title |
|---|
| CSNC200900416012, 増成 彰, "高齢者におけるアルギニンの創傷治癒促進作用", 医学のあゆみ, 1994, 第170巻, 1076−1077 * |
| CSNC200900755017, 伊藤 滋, "骨の成長とホルモン,サイトカイン", 医学のあゆみ, 2001, 第198巻 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007161688A (ja) * | 2005-12-16 | 2007-06-28 | Hiroshima Univ | 軟骨生成促進剤 |
| WO2007111238A1 (ja) | 2006-03-23 | 2007-10-04 | Kyowa Hakko Kogyo Co., Ltd. | 組織コラーゲン合成促進用経口剤 |
| US9433605B2 (en) | 2006-03-23 | 2016-09-06 | Kyowa Hakko Bio Co., Ltd. | Method for promoting synthesis of tissue collagen |
| WO2008072663A1 (ja) * | 2006-12-12 | 2008-06-19 | Ajinomoto Co., Inc. | ステロイド療法における副作用の改善・抑制用組成物 |
| JP2008247896A (ja) * | 2007-03-07 | 2008-10-16 | Shizuokaken Koritsu Daigaku Hojin | 透析患者用経口アミノ酸組成物 |
| KR101485113B1 (ko) * | 2013-04-09 | 2015-01-21 | 롯데푸드 주식회사 | 피부 광노화 예방 및 개선을 위한 프롤린 베이스 혼합 아미노산 조성물 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1582208A2 (en) | 2005-10-05 |
| US7645796B2 (en) | 2010-01-12 |
| US20050250850A1 (en) | 2005-11-10 |
| EP1582208B1 (en) | 2011-08-24 |
| US20060247313A1 (en) | 2006-11-02 |
| EP1582208A3 (en) | 2006-11-22 |
| JP4815752B2 (ja) | 2011-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4815752B2 (ja) | アミノ酸含有飲食品 | |
| EP0347890B1 (en) | Amino acid nutrient compositions | |
| JPS59500966A (ja) | 栄養輸液用アミノ酸溶液、その調製法及び使用法 | |
| JP2009242413A (ja) | アミノ酸をベースとする医薬 | |
| CN108721596B (zh) | 一种复方氨基酸维生素注射液及其应用 | |
| JPS60255722A (ja) | 糖尿病用アミノ酸輸液 | |
| JPH0463049B2 (ja) | ||
| JP2599593B2 (ja) | 腎不全用アミノ酸輸液 | |
| JPH0116809B2 (ja) | ||
| CN1298701A (zh) | 新型复合氨基酸组合物 | |
| JP5370429B2 (ja) | コラーゲン合成促進アミノ酸組成物 | |
| JP2011137037A (ja) | コラーゲン合成促進アミノ酸組成物 | |
| JPH08175987A (ja) | 経口経腸栄養組成物 | |
| JPS6219515A (ja) | 安定な水性脂肪エマルジヨンの製造方法および該エマルジヨンを非経口投与用完全栄養液に使用する方法 | |
| Miwa et al. | Effects of branched-chain amino acid infusion on protein metabolism in rats with acute hepatic failure | |
| JP2008088162A (ja) | 睡眠補助剤および睡眠補助食品 | |
| JP4851046B2 (ja) | 細胞への塩基性アミノ酸取り込み促進剤および医薬組成物 | |
| JP3914585B2 (ja) | マクロファージ一酸化窒素産生亢進剤 | |
| JPH07330583A (ja) | 遊離型グルタミン酸を含有する液状製剤 | |
| Petersson et al. | The long-term effect of postoperative TPN supplemented with glycyl-glutamine on protein synthesis in skeletal muscle | |
| JPH07267855A (ja) | グルタミン産生剤 | |
| WO1995022967A1 (en) | Analgesic activity enhancer | |
| CA2515505C (en) | Inhibitor for perioperative blood sugar elevation | |
| JP2618653B2 (ja) | 肝性脳症患者用アミノ酸製剤 | |
| JPS62135420A (ja) | アミノ酸輸液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20060202 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070110 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100525 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100726 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101209 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110304 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20110512 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110609 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110704 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110708 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20110802 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20110815 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140909 Year of fee payment: 3 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4815752 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140909 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |